glp 1 health concerns The and Healthcare Spending Effects of GLP-1s GLP-1 for Weight Loss and

In December 2020, the FDA issued approval for the drug to be used in adolescents as young as 12 years old with a body weight above 132 pounds (60 kg) with obesity

Pricing structure shows first-month promotional rates for new patients, then ongoing monthly rates

This is called insulin resistance, which can lead to high blood sugar and cause chronic health problems

Al-Brakati A, Alsharif KF, Alzahrani KJ, Kabrah S, Al-Amer O, Oyouni AA, Habotta OA, Lokman MS, Bauomy AA, Kassab RB, Abdel Moneim AE (2021) Using green biosynthesized lycopene-coated selenium nanoparticles to rescue renal damage in glycerol-induced acute kidney injury in rats